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From cyclic polyenes to carbohydrates: synthesis of the hexose
sugar b-allose and its 2C-branched homologue from
cyclooctatetraene
Goverdhan Mehta* and Kotapalli Pallavi
Department of Organic Chemistry, Indian Institute of Science, Bangalore 560 012, IndiaAbstract—In an unconventional but interesting synthetic enterprise, the commercially available hydrocarbon cyclooctatetraene
(COT) has been elaborated to the rare hexose sugar (DL)-b-allose and its 2C-branched analogue. The synthetic sequence delineated
here is notable for its high regio- and stereoselectivity and is flexible enough to enable access to polyoxygenated systems, hexose
sugars, and their siblings from a cyclic polyene precursor.Hexose sugars 1 are among nature’s premier and ubi-
quitous building blocks that are essential for the suste-
nance of diverse biological systems and processes.1
Though many hexose sugars are readily available and
are plentiful, their architecture with a network of
hydroxyl functionalities, and stereochemical nuances
has always posed an attractive ongoing challenge to
synthetic chemists.2 During the last few decades, a
variety of new and interesting strategies have been
developed for the synthesis of hexose sugars and their C-
branched siblings. Branched hexose sugars (e.g., 2) are
interesting in their own right as they constitute the gly-
cosidic component of many antibiotics and have also
received a great deal of attention from synthetic chem-
ists.3 While many synthetic approaches to hexose sugars
and their branched analogues have been explored,2;3 the
possibility of employing a cyclic polyene like cyclo-
octatetraene 3 (COT) for their synthesis appealed to us
as an esoteric and interesting proposition. Herein, we
report the transformation of COT 3 into a rare hexose
sugar (DL)-b-allose and its 2C-branched sibling.4O OH
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* Corresponding author. Tel.: +91-80-22932850; fax: +91-80-236009-
36; e-mail: gm@orgchem.iisc.ernet.inOur synthetic approach to hexose sugars emanated from
bicyclo[4.2.1]nona-2,4,7-trien-9-one 4, a ‘functionally
locked’ cyclooctatetraene, readily available from 3 in a
single pot operation as described by Shechter and co-
workers.5a Baeyer–Villiger oxidation of 4 led to the
lactone 5 and further catalytic OsO4 dihydroxylation,
and acetonide protection led to 6 with complete regio-
and stereocontrol, Scheme 1.5b;6 LAH reduction of 6 led
to the cyclooctadienediol 7 in which the primary
hydroxyl group was selectively protected as the TBS
derivative 8. Ozonolysis of 8 and PCC oxidation of the
resulting product led to the bicyclic lactone 10 through
the intermediacy of the lactol 9 as depicted in Scheme 1.6
Methoxide mediated lactone opening in 10 furnished 11
and the anomeric hydroxyl group was protected as the
methyl ether 12. LAH reduction of 12 revealed the
branched sugar 13 and further deprotections led to (DL)-
methyl-2-deoxy-2C-hydroxymethyl-b-allose 14. The
branched hexose 14 was transformed to the tetraacetate
15 and its X-ray crystal structure determination7
unambiguously secured its formulation.
Next, the 2C-branched precursor 13 was elaborated to
the rare hexose b-allose. Protection of the C5-hydroxyl-
methyl as an acetate 16 and TBS deprotection furnished
17, Scheme 2.6 The primary hydroxyl group in 17 was
transformed to the terminal olefin 18 via mesylate for-
mation and base mediated elimination. Ozonolysis of 18
furnished the intermediate hemiacetal 19, which was
reduced with sodium borohydride to furnish 20,
Scheme 2.6 Acetonide deprotection in 20 delivered
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Scheme 1. Reagents and conditions: (a) OsO4, NMMO, 75%; (b) 2,2-dimethoxypropane, acetone, CSA, 65%; (c) LiAlH4, THF, 80%; (d) TBSCl, Im,
DMF, 54%; (e) O3, DCM–MeOH, DMS; (f) PCC, NaOAc, DCM, 40% for two steps; (g) NaOMe, MeOH; (h) MeI, Ag2O, 73% for two steps; (i)
LiAlH4, THF, 85%; (j) TBAF, THF, 70%; (k) Amberlyst-15, MeOH, 65%; (l) Ac2O, py, DMAP, 90%.
O OMe
OTBSO
O
AcO O
OMe
OHO
O
AcO O OMe
O
O
HO
O OMe
OH
O
O
O
HO OMe
OH
O
O
HOO OMe
OH
OH
HO
HO
13
a b c, d
e
fg
16 17 18
192021
Scheme 2. Reagents and conditions: (a) Ac2O, DMAP, DCM, 92%; (b) TBAF, THF, 74%; (c) MsCl, Et3N, DCM, 65%; (d) KO
tBu, DMSO, 70%; (e)
O3, DCM, DMS, 75%; (f) NaBH4, MeOH, 80%; (g) Amberlyst-15, MeOH, 60%.(DL)-methyl-b-allopyranoside 21 whose spectral char-
acteristics were identical with those reported in the lit-
erature.8
In short, we have accomplished an interesting elabora-
tion of a commercially available polyene (COT) into b-
allose and a 2C-branched congener through a strategy
that should be amenable for adaptation to access other
hexose sugars and some densely oxygenated systems.Acknowledgements
This research was supported by the Chemical and
Biology Unit of JNCASR, Bangalore, India. One of us
(K.P.) would like to thank CSIR (India) for the award
of a research fellowship.References and notes
1. (a) Collins, P. M.; Ferrier, R. J. Monosaccharides: Their
Chemistry and Their Roles in Natural Products. 1st ed.;
Wiley, 1995 (b) Bashkin, J. K. Chem. Rev. 2000, 100, 4265;
(c) Dwek, R. A.; Butters, T. D. Chem. Rev. 2002, 102, 283.
2. (a) Ko, S. Y.; Lee, A. W. M.; Masamune, S.; Reed, L. A.,
III; Sharpless, K. B.; Walker, F. J. Science 1983, 220, 949;
(b) Vogel, P.; Fattori, D.; Gasparini, F.; Le Drian, C.
Synlett 1990, 173; (c) Hudlicky, T.; Entwistle, D. A.;
Pitzer, K. K.; Thorpe, A. Chem. Rev. 1996, 96, 1195; (d)
Takeuchi, M.; Taniguchi, T.; Ogasawara, K. Synthesis
1999, 341; (e) Taniguchi, T.; Takeuchi, M.; Kadota, K.;
ElAzab, A. S.; Ogasawara, K. Synthesis 1999, 1325; (f)
Honzumi, M.; Taniguchi, T.; Ogasawara, K. Org. Lett.
2001, 3, 1355.
3. (a) Yoshimura, J. Adv. Carbohydr. Chem. Biochem. 1984,
42, 69; (b) Wagner, J.; Vogel, P. Tetrahedron 1991, 47,
9641; (c) Beyer, J.; Madsen, R. J. Am. Chem. Soc. 1998,
120, 12137; (d) Kato, K.; Yamamura, S. Nucleosides
Nucleotides 1999, 18, 657.
4. (a) Fukami, H.; Koh, H.-S.; Sakata, T.; Nakajima, M.
Tetrahedron Lett. 1967, 4771; (b) Brimacombe, J. S.;
Hunedy, F.; Husain, A. J. Chem. Soc. C. 1970, 1273; (c)
Singh, U. P.; Brown, R. K. Can. J. Chem. 1971, 49, 1179;
(d) Dondoni, A.; Fantin, G.; Fogagnolo, M.; Medici, A.
Angew. Chem., Int. Ed. Engl. 1986, 25, 835; (e) Vogel, P.;
Auberson, Y. Helv. Chim. Acta 1989, 72, 278; (f) Malle-
ron, A.; David, S. New J. Chem. 1996, 20, 153.
5. (a) Antkowiak, T. A.; Sanders, D. C.; Trimitsis, G. B.;
Press, J. B.; Shechter, H. J. Am. Chem. Soc. 1972, 94, 5366;
(b) Mehta, G.; Pallavi, K. Chem. Commun. 2002, 2828.
6. All compounds reported here are racemic and all new
compounds were characterized on the basis of their IR, 1H
and 13C NMR and mass spectral data. Selected spectral
data: Compound 10: IR (cm1) 1802; 1H NMR (300MHz,
CDCl3) d 6.04 (s, 1H), 4.56–4.51 (m, 2H), 4.24 (d,
J ¼ 7:2Hz, 1H), 3.90 (dd, J ¼ 10:8, 5.7Hz, 1H), 3.72 (t,
J ¼ 10:5Hz, 1H), 2.34–2.26 (m, 1H), 1.47 (s, 3H), 1.30 (s,
3H), 0.89 (s, 9H), 0.06 (s, 6H); 13C NMR (75MHz, CDCl3)
d 107.6, 109.6, 104.5, 73.8, 69.8, 69.4, 60.1, 40.9, 25.9, 25.8
(3C), 24.5, 18.2, 5.5, 5.4; Mass (EI, 70 eV): m=z 345
(Mþ1)þ. Compound 12: 1H NMR (500MHz, CDCl3) d
4.58 (dd, J ¼ 5:5, 4.0Hz, 1H), 4.40 (d, J ¼ 9:0Hz, 1H),
4.34 (dd, J ¼ 7:5, 5.5Hz, 1H), 4.06 (d, J ¼ 7:0Hz, 1H),
3.83–3.79 (m, 1H), 3.79 (s, 3H), 3.70 (t, J ¼ 10:0Hz, 1H),
3.47 (s, 3H), 2.12–2.09 (m, 1H), 1.50 (s, 3H), 1.36 (s, 3H),
0.88 (s, 9H), 0.05 (s, 6H); 13C NMR (75MHz, CDCl3) d
170.2, 109.5, 100.6, 74.7, 72.5, 72.2, 59.5, 56.5, 52.4, 43.5,
27.9, 25.8 (3C), 25.6, 18.3, 5.6, 5.5. Compound 14: 1H
NMR (500MHz, CD3OD) d 4.58 (d, J ¼ 9:0Hz, 1H), 4.17
(t, J ¼ 3:0Hz, 1H), 3.90–3.86 (m, 1H), 3.75–3.69 (m, 4H),
3.44 (s, 3H), 3.46 (dd, J ¼ 9:5, 3.0Hz, 1H), 1.73–1.68 (m,
1H); 13C NMR (75MHz, CD3OD) d 101.7, 75.3, 70.0, 69.7,
63.3, 60.2, 56.9, 48.9; LRMS: m=z 231.1 (MþNa)þ; HRMS
for C8H16O6Na. Calcd: 231.0845. Found: 231.0864. Com-
pound 18: IR (cm1) 3470, 937; 1H NMR (300MHz,
CDCl3) d 5.51 (s, 1H), 5.43 (s, 1H), 5.08 (s, 1H), 4.80 (d,
J ¼ 6:0Hz, 1H), 4.16 (t, J ¼ 7:2Hz, 1H), 3.84 (br d,
J ¼ 10:8Hz, 1H), 3.71 (br d, J ¼ 5:4Hz, 1H), 3.65–3.60
(m, 1H), 3.53 (s, 3H), 1.50 (s, 3H), 1.38 (s, 3H); 13C NMR
(75MHz, CDCl3) d 139.0, 117.6, 109.9, 100.3, 75.9, 75.4,
73.3, 63.1, 56.2, 27.7, 25.7; LRMS: m=z 253.1052
(MþNa)þ; HRMS for C11H18O5Na. Calcd: 253.1053.
Found: 253.1091. Compound 19: IR (cm1): 3412; 1H
NMR (300MHz, CDCl3) d 4.93 (s, 1H), 4.41 (d 1/2 ABq,
J ¼ 7:8, 1.2Hz, 1H), 4.37 (1/2 ABq, J ¼ 8:1Hz, 1H ), 4.27
(dd, J ¼ 9:9, 1.8Hz, 1H), 4.04 (d, J ¼ 1:5Hz, 1H), 3.81 (d,
J ¼ 9:9Hz, 1H), 3.54 (s, 3H), 1.53 (s, 3H), 1.38 (s, 3H); 13C
NMR (75MHz, CDCl3) d 110.9, 98.9, 92.3, 75.7, 75.4,
68.5, 65.0, 55.9, 25.7, 24.5; LRMS: m=z 255.0563(MþþNaþ); HRMS for C10H16O6Na. Calcd: 255.0845.
Found: 255.0846. Compound 21: IR (cm1) 3371;
1H NMR (300MHz, D2O) d 4.42 (d, J ¼ 8:7Hz, 1H),
3.96 (t, J ¼ 3:3Hz, 1H), 3.72 (dd, J ¼ 12:0, 1.8Hz, 1H),
3.63–3.58 (m, 1H), 3.49 (dd as t, J ¼ 6:3Hz, 1H), 3.42 (dd,
J ¼ 9:6, 2.7Hz, 1H), 3.37 (s, 3H), 3.25 (dd, J ¼ 8:4, 3.3Hz,
1H); 13C NMR (75MHz, D2O) d 101.7, 74.1, 71.6, 70.8,
67.4, 61.7, 57.6; LRMS: m=z 217.0528 (MþNa)þ;
HRMS for C7H14O6Na. Calcd: 217.0688. Found:
217.0704.
7. X-ray data for 15: X-ray data were collected at 293K on a
SMART CCD–BRUKER diffractometer with graphite
monochromated MoKa radiation (k ¼ 0:7107A). Struc-
ture was solved by direct methods (SIR92). Refinement was
by full-matrix least-squares procedures on F2 using
SHELXL-97. The nonhydrogen atoms were refined aniso-
tropically whereas hydrogen atoms were refined isotropi-
cally. C16H24O10, MW¼ 376.36, colorless crystal, crystal
system: monoclinic, space group: P2ð1Þ=n, cell parameters:
a ¼ 8:9525 (4)A, b ¼ 20:7773 (10)A, c ¼ 11:2568 (5)A,
b ¼ 111:037 (1), V ¼ 1954:30A3, Z ¼ 4,Dc ¼ 1:279 g cm3,
F(0 0 0)¼ 800.0, l ¼ 0:11mm1. Total number of l.s.
parameters¼ 331, R1¼ 0.0472 for 3179 Fo> 4sig(Fo) and
0.0576 for all 3981 data. wR2 ¼ 0:1400, GOF¼ 1.024,
restrained GOF¼ 1.024 for all data. Crystallographic data
has been deposited with Cambridge Crystallographic Data
Centre. CCDC 232049. ORTEP diagram of 15 is shown
below:
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